Aigen Investment Management, LP Pacira Bio Sciences, Inc. Transaction History

Aigen Investment Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$26.32 - $34.31 $106,438 - $138,749	-4,044 Reduced 37.83%	6,647 $224,000
Q3 2023 Nov 13, 2023	BUY	$30.68 - $40.09 $327,999 - $428,602	10,691 New	10,691 $327,000
Q4 2020 Feb 12, 2021	SELL	$50.47 - $66.26 $2.35 Million - $3.09 Million	-46,582 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$51.97 - $63.0 $828,349 - $1 Million	15,939 Added 52.02%	46,582 $2.8 Million
Q2 2020 Aug 10, 2020	SELL	$30.8 - $52.47 $284,684 - $484,980	-9,243 Reduced 23.17%	30,643 $1.61 Million
Q1 2020 May 08, 2020	BUY	$28.4 - $50.7 $1.13 Million - $2.02 Million	39,832 Added 73762.96%	39,886 $1.34 Million
Q4 2019 Feb 04, 2020	BUY	$36.31 - $46.83 $1,960 - $2,528	54 New	54 $2,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.